(Q40873806)

24 September 2017

1 reference

title

Amyotrophic lateral sclerosis: lessons in trial design from recent trials (English)

1 reference

amyotrophic lateral sclerosis

24 September 2017

main subject

0 references

author name string

Borasio GD

series ordinal

1

1 reference

24 September 2017

publication date

1 October 1997

1 reference

Journal of the Neurological Sciences

24 September 2017

published in

1 reference

24 September 2017

volume

152 Suppl 1

1 reference

24 September 2017

page(s)

S23-8

1 reference

Riluzole for amyotrophic lateral sclerosis

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Continuous response variable trial design in motor neuron disease: long term treatment with a TRH analogue (RX77368).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Riluzole and amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Noninvasive ventilation. Does it work, for whom, and how?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Insulin-like growth factor-I: potential for treatment of motor neuronal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Baseline assessments in amyotrophic lateral sclerosis trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Survival in amyotrophic lateral sclerosis. The role of psychological factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Advance care planning and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2900240-2

10.1016/S0022-510X(97)00240-2

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference